JB Chemicals & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Meeting of the ....
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
JB Chemicals & Pharmaceuticals Ltd has informed BSE that its Board meeting is scheduled for May 11, 2026. The agenda includes approval of standalone and consolidated audited financial results for Q4 and the full year ended March 31, 2026. The board will also consider recommending a final dividend on equity shares for FY 2025-26, subject to shareholder approval. This is a routine intimation under SEBI (LODR) Regulation 29 and was filed on May 5, 2026 by Company Secretary Sandeep Phadnis.
The meeting signals the imminent announcement of FY2026 annual results and a potential dividend for shareholders. This is standard pre-result intimation with no immediate directional signal for the stock.